Key result
Multi-omics network modeling elucidates the complex molecular systems and pathogenic mechanisms underlying NAFLD.
Why the study?
NAFLD is a rapidly growing liver disease with complex etiology, significant economic burden, and no FDA approved therapies, necessitating advanced multi-omics network approaches to uncover pathogenic mechanisms and therapeutic targets.
Multi-tissue multi-omics network approaches offer a promising strategy to uncover pathogenic mechanisms, diagnostic biomarkers, and therapeutic targets for NAFLD.
Multi-omics networks may identify NAFLD gene targets; leaves open clinical translation without prospective validation.
Non-alcoholic fatty liver disease (NAFLD) is a progressive condition of the liver encompassing a range of pathologies including steatosis, non-alcoholic steatohepatitis (NASH), cirrhosis, and hepatocellular carcinoma. Research into this disease is imperative due to its rapid growth in prevalence, economic burden, and current lack of FDA approved therapies. NAFLD involves a highly complex etiology that calls for multi-tissue multi-omics network approaches to uncover the pathogenic genes and processes, diagnostic biomarkers, and potential therapeutic strategies. In this review, we first present a basic overview of disease pathogenesis, risk factors, and remaining knowledge gaps, followed by discussions of the need and concepts of multi-tissue multi-omics approaches, various network methodologies and application examples in NAFLD research. We highlight the findings that have been uncovered thus far including novel biomarkers, genes, and biological pathways involved in different stages of NAFLD, molecular connections between NAFLD and its comorbidities, mechanisms underpinning sex differences, and druggable targets. Lastly, we outline the future directions of implementing network approaches to further improve our understanding of NAFLD in order to guide diagnosis and therapeutics.
No takes yet. Share an insight, caveat, or question.
Blencowe et al. (2019) conducted a review in Non-alcoholic fatty liver disease (NAFLD). Network modeling approaches was evaluated. Network modeling approaches integrating multi-omics data offer a powerful framework to elucidate the complex molecular systems and pathogenic mechanisms underlying non-alcoholic fatty liver disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: